| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2976729 | Journal of Nuclear Cardiology | 2008 | 8 Pages |
Abstract
In this pilot safety study of 48 patients with mild or moderate asthma who had bronchial reactivity to adenosine monophosphate, regadenoson was safe and well tolerated.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Brian R. DM, MRCP(UK), B. MD, FRCP, Trevor T. MD, FRCPath, Peter J. DM, DSc, FRCP, Lixen MS, MPH, Vandana S. MD, FASN, Hsiao D. MD,